Revised radioreceptor assay for beta 2-adrenoceptors expressed on peripheral mononuclear leukocytes by Haen, Ekkehard et al.
JOURNAL OF RECEPTOR RESEARCH, 11(1-4), 129-140 (1991) 
REVISED RADIORECEPTOR ASSAY FOR 62-ADRENOCEPTORS 
EXPRESSED ON PWIPHHlAL MONONUCLEAR LEUKOCYTES 
E. Haen, B. Liebl, T. Lederer', V. Pligka* 
Walther-Straub-Institute of Pharmacology and Toxicology 
Nuss aumstr. 26, D-8000 Miinchen 2, FRG 
'Dept . of Experimental Surgery 
Ismaningerstr. 22, D-8000 Munchen 80, FRG 
"Dept. of Animal Science, Swiss Federal Institute of Technology 
ETH-Zentrum, CH-8092 Zurich, Switzerland 
ABSTRACT 
Peripheral mononuclear leukocytes (pMNL) bear 7 population of R2- 
a&enoceptors. Radioreceptor assays with ( - )  - 2510docyanopindolol 
( I-CYP) are often used to determine the expression of these 
hormone receptors under physiological and pathological conditions. 
Doubts on the occurence of just one class of binding sites as well 
as the availability of new laboratory equipment prompted us to 
revise the procedure employed for investigation of these receptors. 
pMNL were harvested fzom venous hyman blood $y density centrifuga- 
tion with Lymphopaque ' Lymphoprep , or Ficoll yielding immunologi- 
cally distinct pMNL fractions. ceptor binding assays were per- 
formed semi-automatically with "I-CYP in the range from 0.6-600 
pmol/l. Analysis of the data (modified affinity spectra, Scatchard 
plot) revealed two classes of binding sites (high- and low affinity 
binding). The binding isotherms were sigmoidal in the concentration 
range from 0.6-3.0 pmol/l. Parameters estimated for the high affi- 
nity binding site may vary by a factor of 10, depending on the 
mathematical model employed. 
INTRODUCTION 
The expression of fi2-adrenoceptors is often investigated in clinical 
research on peripheral mononuclear leukocytes (pMNL), with the aim 
to correlate changes in their characteristics to the pathophysiology 
and pharmacotherapy of hypertensive (1,2,3,4,5) and asthmatic 
(6,7,8,9,10) diseases. The estimated binding parameters depend 
largely on the assay method and also on the mathematical model 
employed for analysis of the binding isotherm. Until very recently, 
the evaluation of radioreceptor assays for R2-adrenoceptors was based 
on the assumption of one homogenous class of binding sites for the 
radioligand '2510do-cyanopindolo1 ('251-CYP) on pMNL ( 1  1 , 1 2 ) .  In such 
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a case, the so-called "Scatchard analysis" is frequently believed 
to be a suitable method for estimating binding parameters. Sandnes 
et al. (13) and Anhaupl et al. (14), however, reported strong 
evidence for the existence of two classes of binding sites for lZ5I- 
CYP on pMNL, yielding curvilinear Scatchard plots. This requires 
nonlinear regression analysis of the binding data and, as far as the 
diagnostic use is concerned, standard conditions for the binding 
experiment. Therefore, we carried out a series of experiments in 
order to optimalize assay conditions for the determination of R2- 
adrenoceptor expression on pMNL that would be suitable for clinical 
research. 
MATERIALS AND METHODS 
Isolation of human peripheral mononuclear leukocytes (PMNL) 
Venous blood was withdrawn from the antecubital vein of healthy 
subjects into a syringe containing 10 mg/ml EDTA between 9 : 0 0  and 
1 O : O O  a.m. (15). Immediately after venipuncture, intact peripheral 
mononuclear leucocytes were harvested by density centrifugation for 
30 minutes at 4OC and 1600 x g using LymphopaqueR, LymphoprepR (both 
supplied by Nyegaard & Co. AS, Oslo/Norway) or FicollR (Biochrom GmbH 
& Co, Berlin/FRG). pMNL were washed twice in HH buffer pH 1.4 (HEPES 
buffered Hankls salt solution: 1.26 mmol/l CaClZ, 5 . 4  mmol/l KC1, 
0.44 mmol/l KH2P04, 0 .0  mmol/l MgS04, 136.9 mmol/l NaC1, 0.42 mmol/l 
Na2HPO4, 4.3 mmol/l NaHCQ3, 25 mmol/l HEPES; the reagents were pur- 
chased from Merck DarmstadtlFRG) and finally resuspended in HH 
buffer at a concentration of 5 x 106ce11s/ml. Cells were counted 
both in a Coulter Counter (Coulter Electronics, Dusseldorf/FRG) and 
in a light microscope (Neubauer chamber). Using the trypan blue 
exclusion method, the proportion of non-viable cells (i.e. the cell 
fraction stained by the dye) was less than 5%. 
Quantitative evaluation of lymphocyte subpopulations 
Five portions (100 p1) of the pMNL suspension were incubated for 30 
min at 4OC in the dark with 10 p1 of commercially available FITC 
(fluorescein-hsothiocyanate)-labelled monoclonal antibodies (Becton 
& Dickinson GmbH, HeidelberglFRG). The antibodies were directed 
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against cell surface epitopes defined as CD3 (T-lymphocytes), CD4 
cytes/macrophages), and CD19 (B-lymphocytes), respectively (CD, 
- cluster definition). After washing out the excess antibody with 
buffered saline, labelled cells were fixed in 0.1% paraformaldehyde 
and stored at 4OC. Within one week of preparation, cells were run on 
a f luorescence-activated flow cytometer (FACScanR, Becton & Dickin- 
son GmbH, HeidelbergfFRG) to determine the fraction of fluorescence- 
labelled cells ( %  of gated cells). Forward and right angle light 
scatter gates were set to include mononuclear cells. 
(Theiper/inducer-cellS) , CD8 ( Tsuppressor/cytotox.-ce115) , CD14 (mono- 
Radioreceptor assay 
100 p1 of the pMNL suspension were incubated in a total reaction 
volume of 1000 p1 for 2h at 37'12 with various concentrations of 
( - )  -'2510docyanopindolo1 ( '251-CYP, 2000 pCi/mmol, Amersham Buchler, 
Braunschweig/FRG) in the range from 0.6-600 pmol/l. The reaction was 
started by manual addition of the lymphocyte suspension and stopped 
by centrifugation for 10 min at 10000 x g in an Eppendorf-Hermle 
centrifuge Model Z 380 (Eppendorf Hamburg/FRG). Radioactivity of the 
pellets (total binding T) was assessed by gamma-counting. Unspecific 
binding (U) of the radioligand was determined in parallel incuba- 
tions with mol/l (-)-timolol. Timolol was added in a volume of 
20 p1. If not stated otherwise, a Tecan Robotic Sample Processor 
Model 5052 (dual arm system; Zinsser Analytic - Tecan Robotics, 
Frankfurthain FRG) was used for pipetting; software designed by B .  
Liebl for this type of experiments was employed. 
Data analysis 
Specific binding was calculated as a difference between total and 
unspecific binding (cb = T - U). A binding equation for two indepen- 
dent classes of binding sites (see below) was fitted to the data by 
nonlinear regression analysis ( 1 6 ,  or the commercially available 
programms E m f  itterR or SigmaplotR) yielding estimates of the binding 
parameters for the high and low affinity binding sites. Prior to 
this computation, "affinity spectra" were assessed using a recently 
described computational procedure (17). J
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Table 1 
Fractional distibution of lymphocyte subsets in venous blood ob- 
tained from three healthy men (28-36 years of age). Blood was with- 
drawn between 9:00 and 1O:OO a.m. 
( %  of gated cells 5 standard error of the mean) 
LymphopaqueR LymphoprepR FicollR 
CD3 61.7 5 3.8 66.2 5 2.8 70.8 5 2.0 
CD4 33.0 2 3.5 36.3 5 4.2 40.1 5 4.4 
CD8 21.4 5 3.0 21.7 5 1.7 23.0 5 1.6 
CD14 15.4 5 2.0 15.1 5 3.0 14.3 5 1.7 
CDl9 5.8 2 1.2 8.1 2 2.2 9.2 2.0 
CD3 : pan T-lymphocytes; CD4 :C~~g,per-inducer-cells; 
‘’8: T up ress r/c t tox.-cells; CDl9: %-fymp%odYyges 
. monocytes/macrophages; 
RESULTS 
Isolation of peripheral mononuclear leucocvtes (PMNL) 
Density centrifugation with LymphopaqueR (density of 1.086 g/ml) 
yielded more cells than density centrifugation with LymphoprepK or 
FicollR (density of 1.077g/ml). The fractional distribution of lym- 
phocyte subsets was different for the three commercially available 
separation media (Tab. 1 ) . In general, LymphopaqueR yielded less T- 
and B- lymphocytes (CD3-, CD4-, CD8-, and CD19-positive cells, re- 
spectively) but slightly more monocytes (CDl4-positive cells). 
Cell counts in the Coulter Counter were somewhat larger than in the 
Neubauer chamber, presumably because some small detriments and ery- 
throcytes were still detected in the sample. If the gate on the 
Coulter Counter was set to allow the passage of just mononuclear 
cells, cell counts were identical in both methods. 
Radioreceptor assay 
Affinity spectra investigated in a concentration range from 0.6 - 
600 pmol/l 1251-CYP revealed several classes of binding sites (Fig. 
l), two of them being significant in the sense mentioned in our 
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Fig. 1. Affinity spectra for the binding of '251-CYP to human pe- 
ripheral mononuclear leukocytes in a concentration range of 0.6- 
600 pmol/l obtained by the STEP routine ( 1 7 ) .  Vertical lines de- 
note estimates of Kd's (abscissa) from partial sequences of bin- 
ding data. Ordinate: probability scale that expresses the signifi- 
cance of such an esLimate ( p  is the significance of correlation 
coefficient for the linearized Scatchard plot", cf ref. 1 7 ) .  Two 
clusters of binding sites (significance p < 0.01 ) can be seen in 
the graph. 
earlier report ( 1 7 ) .  Binding isotherms within this concentration 
range were sigmoidal at low ligand concentrations, yielding a 
"paradoxical" course (an increase) in the corresponding Scatchard 
plot (Fig. 2 ) .  This confirms the existence of a multiple binding 
site population on pMNL, and suggests that the Hill coefficient of 
at least the high affinity binding site is larger than one. Thus, we 
have employed for nonlinear regression analysis a mathematical model 
of two classes of saturable binding sites assuming that both Hill 
coefficients may potentially differ from one: 
In this equation, B, stands for maximal binding capacity of the cor- 
Jo
ur
na
l o
f R
ec
ep
to
rs
 a
nd
 S
ig
na
l T
ra
ns
du
ct
io
n 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 o
f R
eg
en
sb
ur
g 
on
 0
2/
17
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
134 
\ 
nAm ET A L .  
+ 
LL 
\ 
m 
2oo 1 Scatchard Plot  
l5OIf  100 
:"1 0 .  
3 
/ I) 
0 2000 4000 6000 8000 
Fig. 2. Binding isotherm for the binding of 1251-CYP to human pe- 
ripheral mononuclear leukocytes in a concentration range of 0.6 - 
600 pmol/l. Upper panel: Direct plot of the binding data (free/ 
bound concentration). Lower panel: Scatchard plot. The mathemati- 
cal model of one class of saturable bindin?, sites (high affinity 
binding) and one class of non-saturated (or unsaturable") binding 
sites (low affinity binding) including a Hill coefficient (equa- 
tion 2) was iteratively fitted to the binding data. J
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Table 2 
Binding parameters (parameter value 5 standard error estim%,ed by 
nonlinear regression analysis) of the high and low affinity I-CYP 
binding sites expressed on pMNL obtained from a worn 26 years of 
age. Radioreceptor assa with 19 concentrations of i4T351-CYP in the 
range of 0.6 - 600 pmolrl. Blood was withdrawn at 9:00 a.m. 
2 saturable 
binding sites 
1 saturable, 1 "unsaturable" 
binding site 
B, 1513 5 692 sites/cell 1677 2 185 sites/cell 
Kdl 14.76 5 2.47 pmol/l 16.75 5 2.16 pmol/l 
"1 1.59 5 0.27 1.53 5 0.11 
Bm2 10062 A 17984 sites/cell _ _ _ _ _ -  
Kd2 1485 2 5612 pmol/l _---__ 
1.14 1.05 _ - _ - _ _  "2 
C -__--_ 9.08 5 1 .06  sites*l/cell/pmol 
responding site, Kd for its dissociation constant and n for the Hill 
coefficient; indices 1 and 2 denote high and low affinity sites, re- 
spectively. Binding parameters estimated by nonlinear regression 
analysis (see above) are given in Tab. 2. 
Table 2 indicates that the affinity of the low affinity binding site 
differs from the high affinity binding site by a factor of 100. Kd 
of the second binding site lies obviously above the upper limit of 
the ligand concentration range employed in the experiments. Parame- 
ter estimates are thus rather uncertain for the low affinity binding 
site, as seen from the large standard errors estimated by nonlinear 
regression analysis. We have therefore applied a simplified mathe- 
matical model, suitable for the combination of one saturable (high 
affinity) binding site with a non-saturated (or "unsaturable") low 
affinity binding site. In this model, the second term is replaced by 
a term expressing the binding linearly proportional to the ligand 
concentration (C is an empirical proportionality constant): 
cb = B, * Cfnl / ( K d , ,  + Cfn') + C * Cf (2) 
It should be mentioned that in case of non-saturated low affinity 
sites (c, c <  K d 2 )  the new term should be precisely (Bm2 / K d z )  * cfnZ. 
However, since the estimated n2 seems to be close to one (Tab. 2 ) ,  
linearity can be assumed. In Tab. 2, the C constant ( 9 . 0 8 )  is indeed 
close to the ratio Bm7 / Kd3 ( 6 . 8 ) .  
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Without further statistical testing, it is obvious that estimates of 
binding parameters for the high affinity binding site, obtained by 
the two mathematical models, are very similar. The use of equation 
2 in the 1251-CYP concentration range of 0.6 - 600 pmol/l appears 
therefore more adequate. 
DISCUSSION 
Many clinical studies on the pathophysiology and pharmacotherapy of 
hypertension and bronchial asthma focus on the expression of R-adre- 
noceptors. The receptor parameters are usually determined on blood 
cells (peripheral mononuclear leukocytes) that may be easily and 
repeatedly collected without causing undue discomfort to the 
patients. The estimated parameters, however, are highly variable and 
depend on methodology and concept of the performed assays, as well 
as on the reagents used. 
For example, different R2-adrenoceptor densities have been described 
for various lymphocyte subpopulations (12,18,19). Results of radio- 
receptor assays may thus be influenced by variations in the fractio- 
nal distribution of lymphocyte subsets in the pMNL fraction isolated 
from venous blood for the assays. This study demonstrates that, 
apart from physiological variations, this might occur by using 
different commercially available separation media for cell harves- 
ting. 
Until very recently, most of these studies have been carried out in 
a limited concentration range of the radioligand (10-150 pmol/l 
(ll), or 5-80 pmol/l (9)). Estimates of binding parameters assumed 
the occurence of just one class of binding sites (high affinity 
binding). Such investigations led to the description of a positive 
correlation between the expression of B2-adrenoceptors (number of 
high affinity binding sites per cell) and the elevation of blood 
Fig. 3 .  Relationship between va&e of statistically estimated pa- 
rameters for the high affinity I-CYP binding site on pMNL, con- 
centration range investigated (highest concentration indicated on 
x-axis), and mathematical model employed for the analysis of the 
binding isotherm. 
1 B.s.: one saturable binding site; 2 B . s . :  two independent, satu- 
rable binding sites; s + s: saturated high affinity and saturated 
low affinity binding sites; s + u: saturatEd hi,?h affinity and 
non-saturated low affinity binidng sites; Hill : Hill coeffi- 
cients were fitted). 
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138 HAEN ET A L .  
pressure in hypertension (1,3). Reinhardt et al., however, noted in 
1984 great variations in 1251-CYP binding at higher concentrations 
(9). Extension of the concentration range to higher concentrations 
of the radioligand soon revealed a second, independent class of 
binding sites (13,14). Until now, the biological significance of 
these low affinity binding sites has not been clear. It has been 
suggested that they could represent a reduced receptor state 
resulting from the agonist-receptor interaction in vivo; the high 
affinity binding site is generally assumed to be the functional R2- 
adrenoceptor (13,20). 
The equilibrium dissociation constant of these low affinity binding 
sites for 1251-CYP is in the order of 400 - 1500 pmol/l. An exact 
determination of the binding parameters of the low affinity binding 
site affords radioligand concentrations up to 2-8 nmol/l. The high 
radioligand concentrations present a considerable radiation exposure 
for the persons involved in the experiment. By employing the sample 
processor, radioactive exposure was minimized to the time of trans- 
fering the reagent blocks from the sample processor to the water - 
bath, then to the centrifuge, and back to the sample processor. 
After preparing the radioligand working solution, no further direct 
contact with radioactivity is necessary. 
Nevertheless, under clinical conditions such assays are limited by 
the large quantity of cells needed for the analysis and by the high 
costs for the radioligand. Therefore, we suggest to carry out the 
radioreceptor assays in a concentration range from 0.6 - 150 pmol/l 
and to evaluate the binding data by employing the mathematical model 
of saturable high affinity binding and non-saturated low affinity 
binding expressed by equation 2. With this approach, we could not 
observe any difference in the number of R2-adrenoceptors in patients 
suffering from bronchial asthma, as compared to healthy subjects; 
however, the affinity of the binding sites for the radioligand was 
significantly decreased in these patients (10). 
Basically, any approach using a restricted range of ligand concen- 
trations is not satisfactory. In the clinical research, however, 
certain compromises have to be met in order to make investigation at 
all possible. When the various evaluation procedures currently used 
in clinical reports were compared on the same set of data (Fig. 3), 
it became obvious that a mathematical model of one class of high 
affinity binding sites results invariably in an overestimation of 
the receptor parameters. Whether such an approach is at all accep- 
table, is disputable, for example in certain conditions, like in 
pediatrics, where only a very limited amount of blood may be drawn 
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from the patient for lymphocyte preparation. It has to be kept in 
mind, however, that no restricted concentration range is reliable: 
even a small variation in the binding isoterms will cause dramatic 
variations in the parameter estimates. 
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